Financhill
Sell
17

XTIA Quote, Financials, Valuation and Earnings

Last price:
$0.04
Seasonality move :
-18%
Day range:
$0.04 - $0.04
52-week range:
$0.04 - $7.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
34.67x
Volume:
77.7M
Avg. volume:
89.8M
1-year change:
-99.28%
Market cap:
$6.5M
Revenue:
$4.6M
EPS (TTM):
-$5.47
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $6.1M $4.6M
Revenue Growth (YoY) -- -- -- -- -25.32%
 
Cost of Revenues -- -- -- $2.1M $1.5M
Gross Profit -- -- -- $4M $3.1M
Gross Profit Margin -- -- -- 65.28% 68.04%
 
R&D Expenses -- -- $2.7M $4.5M $4.4M
Selling, General & Admin -- -- $14.6M $16.3M $17.6M
Other Inc / (Exp) -- -- -$400.8K -$1.6M -$9.9M
Operating Expenses -- -- $17.3M $21.6M $22.8M
Operating Income -- -- -$17.3M -$17.7M -$19.7M
 
Net Interest Expenses -- -- -- $600K $4.7M
EBT. Incl. Unusual Items -- -- -$18.4M -$19.9M -$34.3M
Earnings of Discontinued Ops. -- -- -- -$46.6M -$12.8M
Income Tax Expense -- -- -- -$181K $24K
Net Income to Company -- -- -$18.4M -$66.3M -$47.1M
 
Minority Interest in Earnings -- -- -- $2.9M $1.2M
Net Income to Common Excl Extra Items -- -- -$18.4M -$63.4M -$45.9M
 
Basic EPS (Cont. Ops) -- -- -$30.69 -$3,412.09 -$76.42
Diluted EPS (Cont. Ops) -- -- -$30.69 -$3,412.09 -$76.42
Weighted Average Basic Share -- -- $601.2K $23.3K $601.2K
Weighted Average Diluted Share -- -- $601.2K $23.3K $601.2K
 
EBITDA -- -- -$17.7M -$11.1M -$26.6M
EBIT -- -- -$17.8M -$19.3M -$29.6M
 
Revenue (Reported) -- -- -- $6.1M $4.6M
Operating Income (Reported) -- -- -$17.3M -$17.7M -$19.7M
Operating Income (Adjusted) -- -- -$17.8M -$19.3M -$29.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $918K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $398K
Gross Profit -- -- -- -- $520K
Gross Profit Margin -- -- -- -- 56.65%
 
R&D Expenses -- -- -- $472K $1.2M
Selling, General & Admin -- -- -- $1.2M $3.3M
Other Inc / (Exp) -- -- -- -$713K $3K
Operating Expenses -- -- -- $1.7M $4.7M
Operating Income -- -- -- -$1.7M -$4.2M
 
Net Interest Expenses -- -- -- -- $222K
EBT. Incl. Unusual Items -- -- -- -$2.7M -$4.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$2.7M -$4.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$2.7M -$4.4M
 
Basic EPS (Cont. Ops) -- -- -- -$4.50 -$0.13
Diluted EPS (Cont. Ops) -- -- -- -$4.50 -$0.13
Weighted Average Basic Share -- -- -- $601.2K $35M
Weighted Average Diluted Share -- -- -- $601.2K $35M
 
EBITDA -- -- -- -$2.4M -$3.9M
EBIT -- -- -- -$2.4M -$4.2M
 
Revenue (Reported) -- -- -- -- $918K
Operating Income (Reported) -- -- -- -$1.7M -$4.2M
Operating Income (Adjusted) -- -- -- -$2.4M -$4.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $6.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $2.3M
Gross Profit -- -- -- -- $4.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $2.1M $5.9M
Selling, General & Admin -- -- -- $5.9M $31.2M
Other Inc / (Exp) -- -- -- -$1.8M -$8.8M
Operating Expenses -- -- -- $8M $38.4M
Operating Income -- -- -- -$8M -$34M
 
Net Interest Expenses -- -- -- -- $4.4M
EBT. Incl. Unusual Items -- -- -- -$10.8M -$47.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $40K
Net Income to Company -- -- -- -$10.8M -$60M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$10.8M -$58.8M
 
Basic EPS (Cont. Ops) -- -- -- -$18.00 -$5.47
Diluted EPS (Cont. Ops) -- -- -- -$18.00 -$5.47
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -$9.8M -$39.1M
EBIT -- -- -- -$9.8M -$42.7M
 
Revenue (Reported) -- -- -- -- $6.7M
Operating Income (Reported) -- -- -- -$8M -$34M
Operating Income (Adjusted) -- -- -- -$9.8M -$42.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $2.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $846K
Gross Profit -- -- -- -- $1.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $1.8M $1.3M $2.8M
Selling, General & Admin -- -- $7M $5M $18.6M
Other Inc / (Exp) -- -- -$1.1M -$1.8M -$631K
Operating Expenses -- -- $8.8M $6.3M $21.9M
Operating Income -- -- -$8.8M -$6.3M -$20.5M
 
Net Interest Expenses -- -- -- -- $570K
EBT. Incl. Unusual Items -- -- -$10.3M -$8.9M -$21.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $16K
Net Income to Company -- -- -$10.3M -$8.9M -$21.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$10.3M -$8.9M -$21.7M
 
Basic EPS (Cont. Ops) -- -- -$17.11 -$14.80 -$1.68
Diluted EPS (Cont. Ops) -- -- -$17.11 -$14.80 -$1.68
Weighted Average Basic Share -- -- $1.2M $1.8M $55.1M
Weighted Average Diluted Share -- -- $1.2M $1.8M $55.1M
 
EBITDA -- -- -$9.9M -$8.1M -$20.5M
EBIT -- -- -$9.9M -$8.1M -$21.2M
 
Revenue (Reported) -- -- -- -- $2.2M
Operating Income (Reported) -- -- -$8.8M -$6.3M -$20.5M
Operating Income (Adjusted) -- -- -$9.9M -$8.1M -$21.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $4.3M $9.3M $6.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $1.2M $568K
Inventory -- -- -- $2M $2.4M
Prepaid Expenses -- -- $79.4K -- --
Other Current Assets -- -- -- $2.7M $430K
Total Current Assets -- -- $4.6M $29.9M $20.5M
 
Property Plant And Equipment -- -- $31.6K $869K $612K
Long-Term Investments -- -- -- $666K --
Goodwill -- -- -- -- --
Other Intangibles -- -- $302K $3.5M $2.5M
Other Long-Term Assets -- -- -- $22.7M $145K
Total Assets -- -- $4.9M $57.6M $23.8M
 
Accounts Payable -- -- $454.2K $720K $2.4M
Accrued Expenses -- -- $410K $1.8M $1.2M
Current Portion Of Long-Term Debt -- -- $1.1M -- --
Current Portion Of Capital Lease Obligations -- -- -- $207K $201K
Other Current Liabilities -- -- $6.1M $8.8M $2.9M
Total Current Liabilities -- -- $10M $24.7M $16.9M
 
Long-Term Debt -- -- $3.4M -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $13.4M $25.5M $17M
 
Common Stock -- -- $35.6K -- $3K
Other Common Equity Adj -- -- -- $1.1M $630K
Common Equity -- -- -$8.5M $33.3M $6.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -$1.2M $390K
Total Equity -- -- -$8.5M $32.1M $6.7M
 
Total Liabilities and Equity -- -- $4.9M $57.6M $23.8M
Cash and Short Terms -- -- $4.3M $9.3M $6.3M
Total Debt -- -- -- $12.6M $8.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $511K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $610K
Inventory -- -- -- -- $2.7M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- $1.7M
Total Current Assets -- -- -- -- $10.1M
 
Property Plant And Equipment -- -- -- -- $757K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- $12.7M
Other Intangibles -- -- -- -- $4.8M
Other Long-Term Assets -- -- -- -- $878K
Total Assets -- -- -- -- $29.3M
 
Accounts Payable -- -- -- -- $7.6M
Accrued Expenses -- -- -- -- $1.5M
Current Portion Of Long-Term Debt -- -- -- -- -$356K
Current Portion Of Capital Lease Obligations -- -- -- -- $217K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- $22M
 
Long-Term Debt -- -- -- -- $65K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $22.4M
 
Common Stock -- -- -- -- $6.7M
Other Common Equity Adj -- -- -- -- $524K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $6.9M
 
Total Liabilities and Equity -- -- -- -- $29.3M
Cash and Short Terms -- -- -- -- $511K
Total Debt -- -- -- -- $2.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -$18.4M -$66.3M -$47.1M
Depreciation & Amoritzation -- -- $30K $8.2M $3M
Stock-Based Compensation -- -- $12.5M $3.7M $1M
Change in Accounts Receivable -- -- -$249.6K -$115K -$532K
Change in Inventories -- -- -- -$565K -$1.3M
Cash From Operations -- -- -$4.4M -$34M -$29.2M
 
Capital Expenditures -- -- -- $1.2M $357K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$47.2K $36.4M -$5.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$10M
Special Dividend Paid
Long-Term Debt Issued -- -- $2.6M $12.3M $364K
Long-Term Debt Repaid -- -- -$139.1K -- --
Repurchase of Common Stock -- -- -- -$102.4M --
Other Financing Activities -- -- $5.5M -$5.5M -$566K
Cash From Financing -- -- $8.7M -$34.6M $22.2M
 
Beginning Cash (CF) -- -- $122.9K $52.5M $20.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $4.2M -$32.2M -$12.9M
Ending Cash (CF) -- -- $4.3M $20.2M $7.4M
 
Levered Free Cash Flow -- -- -$4.5M -$35.2M -$29.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$2.7M -$4.4M
Depreciation & Amoritzation -- -- -- $10K $315K
Stock-Based Compensation -- -- -- $164K -$1.9M
Change in Accounts Receivable -- -- -- $13K -$381K
Change in Inventories -- -- -- -- $139K
Cash From Operations -- -- -- -$1.4M -$6.1M
 
Capital Expenditures -- -- -- -- $36K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$3K -$36K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $1.6M --
Long-Term Debt Repaid -- -- -- -$4K -$166K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $1.6M $869K
 
Beginning Cash (CF) -- -- -- $37K $5.8M
Foreign Exchange Rate Adjustment -- -- -- -- $14K
Additions / Reductions -- -- -- $199K -$5.3M
Ending Cash (CF) -- -- -- $236K $511K
 
Levered Free Cash Flow -- -- -- -$1.4M -$6.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$10.8M -$60M
Depreciation & Amoritzation -- -- -- $37.3K $3.6M
Stock-Based Compensation -- -- -- $2.9M $2.1M
Change in Accounts Receivable -- -- -- $140.3K -$731K
Change in Inventories -- -- -- -- -$1M
Cash From Operations -- -- -- -$4.3M -$40.5M
 
Capital Expenditures -- -- -- -- $447K
Cash Acquisitions -- -- -- -- $3M
Cash From Investing -- -- -- -$4.9K -$3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $2.9M $476K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $3.1M $31M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.2M -$12.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$4.3M -$41M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$10.3M -$8.9M -$21.7M
Depreciation & Amoritzation -- -- $18.5K $28K $689K
Stock-Based Compensation -- -- $1.9M $2.8M $3.8M
Change in Accounts Receivable -- -- $38.3K $127K -$72K
Change in Inventories -- -- -- -- $271K
Cash From Operations -- -- -$3.1M -$3M -$14.3M
 
Capital Expenditures -- -- -- -- $93K
Cash Acquisitions -- -- -- -- $3M
Cash From Investing -- -- -$2.9K -$3K $2.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2.9M $3M
Long-Term Debt Repaid -- -- -$20K -$14K -$668K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- $30.2K $3.1M $11.9M
 
Beginning Cash (CF) -- -- $6.8M $525K $7.6M
Foreign Exchange Rate Adjustment -- -- -- -- $8K
Additions / Reductions -- -- -$3.1M $121K $498K
Ending Cash (CF) -- -- $3.7M $646K $8.1M
 
Levered Free Cash Flow -- -- -$3.2M -$3M -$14.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock